Europe Point-Of-Care Testing (POCT) Market Analysis- Size and Forecast 2024-2028

Europe Point-Of-Care Testing Market Size 2024-2028

The Europe point-of-care testing (POCT) market size is forecast to increase by USD 6.75 billion, at a CAGR of 8.38% between 2023 and 2028.

• The market is experiencing significant growth due to several key factors. One of the primary drivers is the increasing geriatric population, as older adults often require frequent health monitoring. Another trend is the shift from conventional testing methods towards rapid medial diagnostic tests, which offer faster results and increased convenience. However, the POCT market also faces challenges, such as product recalls and regulatory compliance, which can impact market growth. Despite these challenges, the market is expected to continue expanding, driven by the need for efficient and accurate diagnostic solutions. The use of advanced technologies in healthcare, such as microfluidics and lateral flow assays, is also expected to fuel market growth In the coming years. Overall, the European POCT market presents significant opportunities for growth In the healthcare sector.

What will be the size of the Europe Point-Of-Care Testing (POCT) Market during the forecast period?

Request Free Sample

• The market encompasses a diverse range of diagnostic tests conducted outside of conventional laboratory processes, primarily in clinical settings such as clinics and hospitals. These tests, including those for medical decisions related to infectious diseases, chronic diseases, and cardiovascular diseases, are gaining significant traction due to their convenience and rapid results. The market is segmented into homecare testing and OTC-based testing, with the latter experiencing notable growth.
• POCT devices are increasingly utilized for infectious illnesses, such as HIV and Ebola virus disease, as well as chronic ailments like diabetes with blood glucose testing. Cardiac markers testing and coagulation testing are other significant applications. Personalized medicine and clinical laboratories further expand the market's reach, streamlining diagnostic management and improving patient care. Overall, the market is poised for continued expansion, driven by the increasing demand for efficient, accurate, and accessible diagnostic solutions.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

• Type
  • OTC testing
  • Prescription- based testing
• Application
  • Blood glucose testing
  • Infectious diseases testing
  • Cardiac markers testing
  • Pregnancy and fertility testing
  • Others
• Geography
  • Europe
    • Germany
    • France
    • Italy

By Type Insights

• The OTC testing segment is estimated to witness significant growth during the forecast period.

Point-of-Care Testing (POCT) in Europe is witnessing significant growth, particularly In the Over-the-Counter (OTC) testing segment. OTC POCT refers to self-administered tests that do not require a prescription, making them accessible and cost-effective. These tests offer rapid and accurate results for diagnosing acute and chronic conditions such as cardiovascular diseases, diabetes, and influenza. OTC POCT is gaining popularity due to its convenience and ability to produce results in minutes, enabling timely diagnostic management. Immunoassays technology, a key POCT technology, is extensively used in OTC testing for medical decision-making in areas like infectious diseases, chronic ailments, and cardiac markers.

The integration of smart devices, mobile healthcare, and molecular diagnostics further enhances the potential of OTC POCT. Clinics, laboratories, home care, and student health clinics are major end-users of POCT devices, and the market is expected to expand further with the increasing adoption of personalized medicine and clinical laboratories. POCT kits, nephrology testing, and hematology testing are other significant segments of the POCT market.

Get a glance at the market share of various segments Request Free Sample

The OTC testing segment was valued at USD 6.17 billion in 2018 and showed a gradual increase during the forecast period.

Market Dynamics

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

What are the key market drivers leading to the rise in adoption of Europe Point-Of-Care Testing (POCT) Market?

The growing geriatric population is the key driver of the market.

• The market is witnessing significant growth due to the increasing prevalence of medical conditions such as infectious diseases and chronic diseases among the aging population. According to the World Health Organization, Europe has a substantial geriatric population, with countries like Italy, Germany, France, Sweden, and Spain having over 20% of their populations aged 65 and above. This demographic trend, coupled with the higher susceptibility of the elderly to medical conditions, is driving the demand for POCT devices. Infectious diseases, including HIV and Ebola virus disease, and chronic ailments such as diabetes, cardiovascular diseases, and cancer, are major health concerns in Europe.
• POCT devices enable medical decision-making at the point of care, making them essential for disease detection and diagnostic management. The OTC-based testing segment, which includes homecare testing for blood glucose, cardiac marker testing, coagulation testing, urinalysis testing, pregnancy & fertility testing, tumor marker testing, critical care testing, HbA1c testing, clinical chemistry testing, bilirubin testing, hematology testing, and nephrology testing, is a significant contributor to the market's growth. Advancements in technology, such as immunoassays technology, biosensors technology, molecular diagnostics, and smart devices, are transforming the POCT market. POCT devices are increasingly being integrated into mobile healthcare and clinical laboratories, making disease diagnosis and management more accessible and convenient.

What are the market trends shaping the Europe Point-Of-Care Testing (POCT) Market?

The shift from conventional testing methods to rapid diagnostic test is the upcoming trend In the market.

• Point-of-Care Testing (POCT) in Europe is witnessing significant growth due to the increasing demand for faster medical decision-making, particularly In the diagnosis of infectious diseases and chronic conditions. Homecare testing, including the OTC-based testing segment, is gaining popularity for its convenience and ability to provide immediate results. POC tests, such as immunoassays technology, are increasingly being used in student health clinics, clinics, and hospitals for disease detection. In Europe, POCT devices are being utilized for various applications, including Blood Glucose Testing, Cardiac Marker Testing, Coagulation Testing, infectious disease Testing, Urinalysis Testing, Pregnancy & Fertility Testing, Tumor Marker Testing, Critical Care Testing, HbA1c Testing, Clinical Chemistry Testing, Bilirubin Testing, and Hematology Testing.
• The emergence of smart devices, mobile healthcare, and molecular diagnostics, such as PCR, is further fueling the growth of the POCT market. POCT is particularly useful for diagnosing infectious illnesses, such as HIV and Ebola virus disease, and managing chronic ailments, including cardiovascular diseases. POCT is transforming diagnostic management by enabling personalized medicine and reducing the reliance on conventional laboratory processes. Clinical laboratories are increasingly adopting POC kits to provide quicker results and improve patient care. The use of biosensors technology and nephrology testing is also on the rise. Sensible Diagnostics, Response Biomedical, Ortho Clinical Diagnostics, and other leading players are innovating In the POCT market to meet the evolving needs of healthcare providers and patients.

What challenges does Europe Point-Of-Care Testing (POCT) Market face during the growth?

product recalls in POCT market is a key challenge affecting the market growth.

• The market is experiencing significant growth due to the increasing demand for medical decision-making in various settings, including infectious diseases and chronic diseases diagnosis. Homecare testing, particularly In the Over-The-Counter (OTC)-based testing segment, is gaining popularity. POC tests, such as Blood Glucose Testing, Cardiac Marker Testing, Coagulation Testing, Infectious Disease Testing, Urinalysis Testing, Pregnancy & Fertility Testing, Tumor Marker Testing, Critical Care Testing, HbA1c Testing, Clinical Chemistry Testing, Bilirubin Testing, and Hematology Testing, are transforming diagnostic management. Immunoassays technology is a key driver in this market, enabling rapid and accurate results. Student health clinics, clinics, laboratories, and hospitals are major users of POCT devices.
• Disease detection in infectious illnesses and chronic ailments, such as HIV, Ebola virus disease, and cardiovascular diseases, is a significant application area. POCT devices, including smart devices and mobile healthcare, are increasingly being integrated into clinical laboratories and home care. Molecular diagnostics, such as Polymerase Chain Reaction (PCR), and biosensors technology, including glucose monitoring and nephrology testing, are also gaining traction. However, product recalls can impact the market, as they affect sales, brand image, and consumer confidence. The FDA recalls POCT products if they pose a health risk or cause patient injury or fatalities.

Exclusive Europe Point-Of-Care Testing (POCT) Market Customer Landscape

The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, market forecast partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence In the market.

The market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• A. Menarini Industrie Farmaceutiche Riunite Srl
• Abbott Laboratories
• ACON Laboratories Inc.
• Becton Dickinson and Co.
• BioMerieux SA
• Chembio Diagnostics Inc.
• Danaher Corp.
• F. Hoffmann La Roche Ltd.
• Fluxergy Inc.
• Johnson and Johnson Services Inc.
• LifeScan IP Holdings LLC
• Nova Biomedical Corp.
• OraSure Technologies Inc.
• PHC Holdings Corp.
• Sd Biosensor Inc.
• Siemens AG
• Sinocare Inc.
• Sysmex Corp.
• Thermo Fisher Scientific Inc.
• Trinity Biotech Plc

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Research Analyst Overview

Point-of-Care Testing (POCT) has emerged as a significant trend in European healthcare, offering various benefits such as quicker diagnosis, improved patient outcomes, and reduced healthcare costs. POCT enables medical professionals to make decisions based on real-time patient data, leading to more effective and personalized treatment plans. POCT plays a crucial role In the detection and management of various medical conditions, including infectious diseases and chronic diseases. Infectious diseases, such as HIV and Ebola virus disease, require swift diagnosis to prevent further spread and ensure timely treatment. POCT devices have proven instrumental in student health clinics and other healthcare facilities, providing accurate results in a short timeframe.

Further, chronic diseases, like cardiovascular diseases, diabetes, and nephrology conditions, necessitate continuous monitoring and frequent testing. POCT devices, such as blood glucose testing and coagulation testing kits, enable patients to manage their conditions effectively at home. The OTC-based testing segment has gained traction in this regard, allowing patients to perform tests independently and conveniently. POCT employs advanced technologies like immunoassays and molecular diagnostics to deliver accurate and reliable results. Immunoassays technology, for instance, is widely used in infectious disease testing, cardiac marker testing, and tumor marker testing. This technology allows for the detection of specific antigens or antibodies in various bodily fluids, providing valuable insights into the presence and progression of diseases.

In addition, the integration of smart devices, mobile healthcare, and POCT has further expanded the market's potential. Smart devices enable real-time data transmission and analysis, while mobile healthcare solutions facilitate remote patient monitoring and timely intervention. These advancements have been particularly beneficial in critical care testing, ensuring that healthcare professionals have access to critical patient information at all times. Personalized medicine is another area where POCT has made significant strides. POCT devices, such as HbA1c testing and clinical chemistry testing, offer healthcare professionals valuable insights into a patient's health status, enabling them to tailor treatment plans accordingly. The market is expected to grow steadily, driven by increasing demand for faster and more accurate diagnostic tools, the rising prevalence of chronic diseases, and the ongoing advancements in technology.

Request Free Sample

What are the Key Data Covered in this Market Research Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the market growth and forecasting between 2024 and 2028
• Precise estimation of the size of the market and its contribution of the market in focus to the parent market
• Accurate predictions about upcoming market growth and trends and changes in consumer behaviour
• Growth of the market across Europe
• Thorough analysis of the market's competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements Get in touch